Kazia Therapeutics Ret. on assets
What is the Ret. on assets of Kazia Therapeutics?
The Ret. on assets of Kazia Therapeutics Limited is -33.41%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on ASX compared to Kazia Therapeutics
What does Kazia Therapeutics do?
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.
Companies with ret. on assets similar to Kazia Therapeutics
- Epigenomics AG has Ret. on assets of -33.48%
- Kogi Iron has Ret. on assets of -33.44%
- ReNeuron plc has Ret. on assets of -33.44%
- Pivotal Systems has Ret. on assets of -33.43%
- East Asia Minerals has Ret. on assets of -33.43%
- Jessy Ventures has Ret. on assets of -33.41%
- Kazia Therapeutics has Ret. on assets of -33.41%
- Moderna Dl ,0001 has Ret. on assets of -33.39%
- Moderna Inc has Ret. on assets of -33.39%
- Equus Mining has Ret. on assets of -33.39%
- Emergent Biosolutions Inc has Ret. on assets of -33.38%
- Litian Pictures has Ret. on assets of -33.34%
- Invion has Ret. on assets of -33.34%